Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exocrine Pancreatic Insufficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00559364
What this trial is testing

Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea

Who this might be right for
Exocrine Pancreatic InsufficiencyChronic PancreatitisPancreatectomy
Forest Laboratories 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07697352
What this trial is testing

Comparative Study to Evaluate Microbial Versus Porcine Pancreatic Enzyme Therapy in Chronic Pancreatitis

Who this might be right for
Pancreatitis, ChronicExocrine Pancreatic Insufficiency (EPI)
Asian Institute of Gastroenterology, India 134
Not applicableEnded earlyNCT04275479
What this trial is testing

Diabetes/ Endocrine Surveillance in SDS

Who this might be right for
Shwachman-Diamond Syndrome
Washington University School of Medicine 11
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)Study completedNCT00559052
What this trial is testing

An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)

Who this might be right for
Exocrine Pancreatic Insufficiency
Axcan Pharma 22
Not applicableStudy completedNCT01879228
What this trial is testing

Effect of Chronic Incretin-based Therapy in Cystic Fibrosis

Who this might be right for
Cystic FibrosisPancreatic Insufficiency
University of Pennsylvania 26
Large-scale testing (Phase 3)Ended earlyNCT04231279
What this trial is testing

Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency

Who this might be right for
Abdominal PainIrritable Bowel Syndrome
Orlando Health, Inc. 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07559175
What this trial is testing

Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.

Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)Cystic Fibrosis (CF)Pancreatic Enzyme Abnormality+1 more
Aimmune Nestlé Health Science US R&D, LLC 66
Testing effectiveness (Phase 2)Study completedNCT03746483
What this trial is testing

OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)Cystic Fibrosis (CF)
Entero Therapeutics 41
Large-scale testing (Phase 3)Study completedNCT00449904
What this trial is testing

Open-Label Phase III Long-Term Safety Trial of Liprotamase

Who this might be right for
Cystic FibrosisExocrine Pancreatic Insufficiency
Anthera Pharmaceuticals 214
Not applicableStudy completedNCT05385211
What this trial is testing

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesExocrine Pancreatic Insufficiency
Ciusss de L'Est de l'Île de Montréal 100
Not applicableStudy completedNCT01144507
What this trial is testing

Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis

Who this might be right for
Cystic FibrosisPancreatic Insufficiency
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 774
Testing effectiveness (Phase 2)Ended earlyNCT00630279
What this trial is testing

Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

Who this might be right for
Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis
Solvay Pharmaceuticals 56
Large-scale testing (Phase 3)Study completedNCT00705978
What this trial is testing

Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis

Who this might be right for
Pancreatic Insufficiency
Abbott Products 62
Large-scale testing (Phase 3)Study completedNCT00401076
What this trial is testing

Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency

Who this might be right for
Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy
Abbott 80
Not applicableStudy completedNCT02979340
What this trial is testing

MRI to Characterize and Predict CF Liver Disease in PUSH Cohort

Who this might be right for
Cystic Fibrosis Liver DiseasePancreatic Insufficiency
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 115
Post-approval studies (Phase 4)Ended earlyNCT00744250
What this trial is testing

Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control

Who this might be right for
Exocrine Pancreatic InsufficiencyChronic PancreatitisCystic Fibrosis
Digestive Care, Inc. 3
Not applicableStudy completedNCT02750501
What this trial is testing

Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study

Who this might be right for
Cystic Fibrosis
Alcresta Therapeutics, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT04375878
What this trial is testing

OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis

Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)Cystic Fibrosis (CF)
Entero Therapeutics 27
Not applicableStudy completedNCT05450627
What this trial is testing

Registry of Pancreatic Exocrine Insufficiency: Enzyme Dose Requirements and Outcomes in Pancreatic Exocrine Insufficiency Across Aetiologies

Who this might be right for
Exocrine Pancreatic Insufficiency
Hospital Clinico Universitario de Santiago 1,015
Next Page